Susquehanna International Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-29,986
| Closed | -$1.13M | – | 6277 |
|
2021
Q1 | $1.13M | Buy |
29,986
+10,813
| +56% | +$407K | ﹤0.01% | 2834 |
|
2020
Q4 | $326K | Buy |
+19,173
| New | +$326K | ﹤0.01% | 3822 |
|
2020
Q3 | – | Sell |
-90,596
| Closed | -$553K | – | 5233 |
|
2020
Q2 | $553K | Buy |
90,596
+53,882
| +147% | +$329K | ﹤0.01% | 2821 |
|
2020
Q1 | $83K | Sell |
36,714
-31,574
| -46% | -$71.4K | ﹤0.01% | 4095 |
|
2019
Q4 | $313K | Buy |
68,288
+1,198
| +2% | +$5.49K | ﹤0.01% | 3104 |
|
2019
Q3 | $260K | Sell |
67,090
-7,635
| -10% | -$29.6K | ﹤0.01% | 3587 |
|
2019
Q2 | $451K | Buy |
+74,725
| New | +$451K | ﹤0.01% | 3027 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 5039 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 5270 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 5153 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 5112 |
|
2018
Q1 | – | Hold |
0
| – | – | – | 4930 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 4809 |
|
2017
Q3 | – | Hold |
0
| – | – | – | 4608 |
|
2017
Q2 | – | Hold |
0
| – | – | – | 4690 |
|
2017
Q1 | – | Hold |
0
| – | – | – | 4786 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 4958 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 4284 |
|
2016
Q2 | – | Hold |
0
| – | – | – | 4374 |
|
2016
Q1 | – | Hold |
0
| – | – | – | 4609 |
|
2015
Q4 | – | Sell |
-44,786
| Closed | -$689K | – | 4759 |
|
2015
Q3 | $689K | Buy |
44,786
+27,609
| +161% | +$425K | ﹤0.01% | 2802 |
|
2015
Q2 | $427K | Sell |
17,177
-14,300
| -45% | -$355K | ﹤0.01% | 3494 |
|
2015
Q1 | $719K | Buy |
+31,477
| New | +$719K | ﹤0.01% | 2759 |
|